carbostyril has been researched along with Carcinoma, Anaplastic in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (18.18) | 18.2507 |
2000's | 3 (27.27) | 29.6817 |
2010's | 5 (45.45) | 24.3611 |
2020's | 1 (9.09) | 2.80 |
Authors | Studies |
---|---|
Choi, HY; Gualberto, A; Jeong, BC; Kwon, GY; Lee, HW; Park, SH; Sa, JK; Scholz, C; Sung, HH | 1 |
Bjarnason, GA; Edeline, J; Escudier, B; Faivre, S; Fartoux, L; Germann, N; Hirte, H; Jones, R; Mackay, H; Oza, A; Plummer, R; Pouget, JC; Thistlethwaite, F; Van Cutsem, E; Vergote, I | 1 |
Chen, SS; Lin, ML; Ng, SH | 1 |
Chaurasia, M; Chowdhury, T; Das, S; Dey, KK; Mandal, M; Pal, I; Parida, S; Rajesh, Y; Sharma, K | 1 |
Akhmedjanova, V; Aubert, C; Ciccolini, J; Ea, S; Giacometti, S | 1 |
Agarwal, N; Sonpavde, G; Sternberg, CN | 1 |
Baek, IH; Baik, GH; Choi, MH; Jang, HJ; Kae, SH; Kim, HY; Kim, JH; Kim, KH; Kim, KO; Kim, SJ; Park, CH; Shin, WG | 1 |
Chao, JI; Hsu, TS; Kuo, PC | 1 |
Chao, JI; Chen, C; Chiu, SJ; Hsu, TS; Lee, PT; Liu, HF; Tsai, CC | 1 |
Beumer, H; Hoepelman, AI; Rozenberg-Arska, M; Verhoef, J; Visser, MR | 1 |
Arakawa, H; Iguchi, T; Kurama, M; Mano, E; Nakagawa, S; Okura, A; Tanaka, N; Yoshinari, T | 1 |
1 review(s) available for carbostyril and Carcinoma, Anaplastic
Article | Year |
---|---|
Novel molecular targets for the therapy of castration-resistant prostate cancer.
Topics: Abiraterone Acetate; Androstadienes; Anilides; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Benzamides; Bone Neoplasms; Cancer Vaccines; Carcinoma; Clinical Trials, Phase III as Topic; Clusterin; Dasatinib; Denosumab; Humans; Ipilimumab; Male; Nitriles; Orchiectomy; Phenylthiohydantoin; Prostatic Neoplasms; Pyridines; Pyrimidines; Quinolines; Quinolones; Radium; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Taxoids; Thiazoles; Tissue Extracts; Treatment Outcome; Vaccines, Synthetic | 2012 |
3 trial(s) available for carbostyril and Carcinoma, Anaplastic
Article | Year |
---|---|
A Phase II Trial of Tipifarnib for Patients with Previously Treated, Metastatic Urothelial Carcinoma Harboring
Topics: Aged; AMP-Activated Protein Kinase Kinases; Carcinoma; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Mutation; Neoplasm Metastasis; Progression-Free Survival; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins p21(ras); Quinolones; Urothelium | 2020 |
A Phase II Multicentre, Open-Label, Proof-of-Concept Study of Tasquinimod in Hepatocellular, Ovarian, Renal Cell, and Gastric Cancers.
Topics: Antineoplastic Agents; Carcinoma; Disease-Free Survival; Female; Humans; Kaplan-Meier Estimate; Kidney Neoplasms; Liver Neoplasms; Male; Ovarian Neoplasms; Quinolones; Stomach Neoplasms | 2017 |
Can rebamipide and proton pump inhibitor combination therapy promote the healing of endoscopic submucosal dissection-induced ulcers? A randomized, prospective, multicenter study.
Topics: Adenoma; Aged; Alanine; Anti-Ulcer Agents; Carcinoma; Chi-Square Distribution; Confidence Intervals; Dissection; Drug Therapy, Combination; Female; Gastric Mucosa; Gastroscopy; Humans; Male; Middle Aged; Odds Ratio; Proton Pump Inhibitors; Quinolones; Stomach Neoplasms; Stomach Ulcer | 2012 |
7 other study(ies) available for carbostyril and Carcinoma, Anaplastic
Article | Year |
---|---|
CHM-1 Suppresses Formation of Cell Surface-associated GRP78-p85α Complexes, Inhibiting PI3K-AKT Signaling and Inducing Apoptosis of Human Nasopharyngeal Carcinoma Cells.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma; Cell Line, Tumor; Cell Membrane; Cell Proliferation; Dioxoles; Endoplasmic Reticulum Chaperone BiP; Heat-Shock Proteins; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Phosphatidylinositol 3-Kinase; Protein Multimerization; Proto-Oncogene Proteins c-akt; Quinolones; Signal Transduction | 2015 |
Cooperative effect of BI-69A11 and celecoxib enhances radiosensitization by modulating DNA damage repair in colon carcinoma.
Topics: Apoptosis; Benzimidazoles; Carcinoma; Celecoxib; Colonic Neoplasms; Combined Modality Therapy; DNA Breaks, Double-Stranded; DNA Damage; DNA Repair; HCT116 Cells; Humans; Quinolones; Radiation Tolerance; Radiation-Sensitizing Agents; Radiation, Ionizing; Signal Transduction | 2016 |
Cytotoxic effects of haplamine and its major metabolites on human cancer cell lines.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Digestive System Neoplasms; Fluorouracil; Gemcitabine; Humans; Pyrans; Quinolones; Rutaceae | 2008 |
Down-regulation of survivin in nitric oxide-induced cell growth inhibition and apoptosis of the human lung carcinoma cells.
Topics: Antineoplastic Agents; Apoptosis; Arsenites; Benzazepines; Blotting, Western; Carcinoma; CDC2 Protein Kinase; Cell Cycle; Cell Division; Cell Line, Tumor; Cisplatin; Dose-Response Relationship, Drug; Down-Regulation; Fluorescent Antibody Technique, Indirect; G2 Phase; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Indoles; Inhibitor of Apoptosis Proteins; Lung Neoplasms; Male; MAP Kinase Signaling System; Microtubule-Associated Proteins; Mitogen-Activated Protein Kinases; Mitosis; Neoplasm Proteins; Nitric Oxide; Nitroprusside; p38 Mitogen-Activated Protein Kinases; Penicillamine; Purines; Pyridines; Quercetin; Quinolones; Quinones; Reverse Transcriptase Polymerase Chain Reaction; Survivin; Time Factors; Transfection | 2004 |
7-Chloro-6-piperidin-1-yl-quinoline-5,8-dione (PT-262), a novel synthetic compound induces lung carcinoma cell death associated with inhibiting ERK and CDC2 phosphorylation via a p53-independent pathway.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma; CDC2 Protein Kinase; Cell Count; Cell Cycle; Cell Death; Cell Division; Cell Line, Tumor; Cell Proliferation; Cell Survival; Extracellular Signal-Regulated MAP Kinases; Humans; Lung Neoplasms; Membrane Potentials; Mitochondrial Membranes; Mitogen-Activated Protein Kinases; Phosphorylation; Quinolones; Quinones; Signal Transduction; Tumor Suppressor Protein p53 | 2008 |
Changes in adherence of respiratory pathogens to HEp-2 cells induced by subinhibitory concentrations of sparfloxacin, ciprofloxacin, and trimethoprim.
Topics: Anti-Infective Agents; Bacteria; Bacterial Adhesion; Carcinoma; Ciprofloxacin; Fluoroquinolones; Humans; Laryngeal Neoplasms; Quinolones; Respiratory Tract Infections; Trimethoprim; Tumor Cells, Cultured | 1993 |
Stereo (C7)-dependent topoisomerase II inhibition and tumor growth suppression by a new quinolone, BO-2367.
Topics: Animals; Anti-Infective Agents; Carcinoma; Colonic Neoplasms; DNA Topoisomerases, Type II; DNA, Neoplasm; DNA, Superhelical; Drug Screening Assays, Antitumor; Enzyme Induction; Etoposide; Female; Fluoroquinolones; Leukemia L1210; Leukemia P388; Mice; Mice, Inbred Strains; Quinolones; Stereoisomerism; Topoisomerase II Inhibitors | 1993 |